KAMAL CHAMOUN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CLEVELAND, OH NPI 1639611122
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology OH Takeda Pharmaceuticals U.S.A., Inc. All categories
General Payments — all program years on this page
$952.69
- Category: General Payments
- Program years: PY2018–2019
- Record count: 18
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $348.85 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $198.86 | 4 |
| Education | $149.99 | 2 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $166.31 | 2 |
| Astellas Pharma US Inc | $149.99 | 2 |
| JAZZ PHARMACEUTICALS INC. | $18.60 | 1 |
| Amgen Inc. | $13.95 | 1 |
By program year
Records — PY2019 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 655498721 | Astellas Pharma US Inc | $64.99 | 06/07/2019 | Education | Undisputed | 01/23/2026 | View at CMS |
| 655498725 | Astellas Pharma US Inc | $85.00 | 06/07/2019 | Education | Undisputed | 01/23/2026 | View at CMS |
| 662586885 | Amgen Inc. | $13.95 | 03/18/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 684179261 | JAZZ PHARMACEUTICALS INC. | $18.60 | 01/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 697385881 | Takeda Pharmaceuticals U.S.A., Inc. | $86.83 | 01/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 697388601 | Takeda Pharmaceuticals U.S.A., Inc. | $79.48 | 03/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.